Here, we showed that Bay11-7082, the NF-κB inhibitor, could alleviate the partial EMT and renal fibrosis induced by Snai1 upregulation, as well as resolve the inflammatory response in the interstitium. Here, NFKB1 is linked to renal fibrosis.